Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder Buys $187,620.00 in Stock

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero bought 106,000 shares of the business’s stock in a transaction on Wednesday, March 22nd. The shares were acquired at an average cost of $1.77 per share, for a total transaction of $187,620.00. Following the purchase, the insider now directly owns 2,056,000 shares in […]

Related Keywords

Jamesd Dondero , ,Nasdaq ,Paratek Pharmaceuticals ,Prospera Financial Services Inc ,Paratek Pharmaceuticals Price Performance ,News Ratings For Paratek Pharmaceuticals Daily ,Quarter For Paratek Pharmaceuticals ,Securities Exchange Commission ,Commonwealth Equity Services ,Hedge Funds Weigh In On Paratek Pharmaceuticals ,Ci Private Wealth ,Paratek Pharmaceuticals Inc ,Get Rating ,Exchange Commission ,Financial Services Inc ,Equity Services ,Point Capital Management ,Jane Street Group ,Paratek Pharmaceuticals Daily ,Nasdaq Prtk ,Prtk ,Medical ,89354m10 ,Insider Trading ,Nsider Trades ,Stocks ,